Preclinical Testing of CAR T Cells in a Patient-Derived Xenograft Model of Glioblastoma

Glioblastoma (GBM) is the most common malignant adult brain tumor that is resistant to the standard care therapy. Advances in chimeric antigen receptor (CAR) T cell therapies have spurred renewed interest in developing CAR T cell therapies to target chemoradiotherapy-resistant brain tumor-initiating...

Full description

Saved in:
Bibliographic Details
Published in:STAR Protoc
Main Authors: Tatari, Nazanin, Maich, William T., Salim, Sabra K., Mckenna, Dillon, Venugopal, Chitra, Singh, Sheila
Format: Artigo
Language:Inglês
Published: Elsevier 2020
Subjects:
Protocol
Online Access:https://ncbi.nlm.nih.gov/pmc/articles/PMC7757398/
https://ncbi.nlm.nih.gov/pubmed/33377068
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.xpro.2020.100174
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items